Exosomes, recently discovered "naturally domesticated" biomolecule drug carriers, are being engineered by ANEXT, a clinical-stage biopharmaceutical company, for highly optimized cellular therapeutic approaches. ANEXT is committed to the development of novel approaches for new drug discovery and changes in drug delivery routines.
ANEXT currently supports exosome-engaged therapeutics that have shown incredible promise in the treatment of inflammatory disorders and a range of malignancies. ANEXT has consistently advanced the growth of this discipline, and the outstanding scientific research team based there is always looking into cutting-edge therapies for inflammatory illnesses and tumors that will increase hope fo.
PRECLIN
PROCESS
VALIDATION
ANIMAL
EXPERIMENT
FORMULATION
DEVELOPMENT
IND
Phase I
Phase Ⅱ
Phase Ⅲ
Scale production applications
ANEXT
First
Pipeline
WA®
ANEXT FIT
CELL®
JORIA®
EV-RSV exosome harboring RSV virus fusion protein gene vaccine
XO-CAPSOL-T3 Mesenchymal Cell Exosome Nano-atomizer
EXO-CAPSOL-T3 Mesenchymal Cell Exosome Nano-atomizer
prevention of lower respiratory tract disease(LRTD) caused by RSV (respiratory syncytial virus)
Interstitial Pneumonia (IP)
Skin Inflammation and Damage Repair （ACD）
Pending startup of pipeline with National Pharmaceutical
COCOON
RNA BIO+
ANEXT REJOY®
RNA BIO
ANEXT CAPSOL-T®
FIT SO
EXO Rule
雅百巧
MSC-EXO-Ⅱ mesenchymal stroma in cellular exosomes combined with thin layer envelope
TIME SO-MSC-EXO Mesoderm-derived mesenchymal zygotic cellular exosome filler
EXO ACELL T-1 MSC exosome injection
EXO-CAPSOL-T1 293 Cellular Exosome Injection
EXO-CAPSOL-T2 293 Cellular Exosome Monoclonal Antibody IV Solution
MSC-EXO-V mesenchymal stromal zymosome nanosphere spray
ENOX2 Gene
ENOX2 Gene
retinal repair/ macular degeneration （MD）
generalized baldness, seborrheic dermatitis AAU/SD
Neuroprosthetics/ Parkinson’s disease (PD)
cutaneous T-cell lymphoma (CTCL), melanoma (MEL), breast cancer (BC)
Hepatocellular carcinoma (HCC), Colorectal cancer (CRC)
Rhinitis/Allergic Rhinitis Rhin/AR
Detection oftumor protein circulation
Pharmacologicalevaluation
ANEXT Biological R&D pipeline progress chart
Completed phase
ongoing phase
inessential phase
WA®
ANEXT FIT
CELL®
JORIA®
COCOON
RNA BIO+
ANEXT REJOY®
RNA BIO
ANEXT CAPSOL-T®
FIT SO
EXO Rule
雅百巧
Address: No. 1788, West Huifeng Road, Fengxian District, Shanghai, China
phone: 02160133720
